BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• News

  Syra Health to Participate in Several Upcoming Healthcare and Technology Conferences

  July 3, 2024

   · 

  1 min read
• News

  IntelGenx Obtains Preliminary Efficacy Results for the ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease

  July 3, 2024

   · 

  5 min read
• BD to Announce Financial Results for its Third Quarter of Fiscal 2024

  July 3, 2024

   · 

  2 min read
• Drug Development

  Update: Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products

  July 3, 2024

   · 

  12 min read
• Drug Development

  Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform

  July 3, 2024

   · 

  7 min read
• Business

  Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes

  July 3, 2024

   · 

  4 min read
• Drug Development

  Spectral Medical Provides June 2024 Tigris Trial Update

  July 3, 2024

   · 

  3 min read
• Business

  Accomplished Biotech Leader Michel Dahan Joins Alkeus as President and CEO

  July 3, 2024

   · 

  3 min read
• Drug Development

  Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products

  July 3, 2024

   · 

  12 min read
• Drug Development

  To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA

  July 3, 2024

   · 

  7 min read